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Accepted 30 April 2015A 32-year-old, primigravid woman underwent amniocentesis in
the second trimester due to an abnormal maternal serum screening
result of a Down syndrome risk of 1/44 calculated from a level of
0.78 multiples of the median (MoM) of a-fetoprotein (AFP), a level
of 3.05 MoM of free b-human chorionic gonadotrophin (b-hCG), a
level of 2.66 MoM of inhibin A, and a level of 0.98 MoM of un-
conjugated estriol (E3) at 15 weeks of gestation. Amniocentesis
revealed a karyotype of 46,XY. Prenatal ultrasound ﬁndings were
unremarkable, and the pregnancy was uneventful. A male baby was
delivered smoothly at termwith a bodyweight of 3674 g and a body
length of 49 cm. The infant postnatally manifested characteristic
facial appearance of Kleefstra syndrome, intellectual disability, and
developmental delay. Array comparative genomic hybridization
(aCGH) analysis of the peripheral blood revealed an 8.08-kb 9q34.3
microdeletion or arr 9q34.3 (140,687,823e140,695.906)1
encompassing an OMIM gene of EHMT1 consistent with the diag-
nosis of Kleefstra syndrome.
The present case had an 8.08-kb 9q34.3 microdeletion encom-
passing the EHMT1 gene and manifested characteristic Kleefstra
syndrome and 9q subtelomeric deletion syndrome. Kleefstra* Corresponding author. Department of Obstetrics and Gynecology, Mackay
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erozygous mutations of the EHMT1 gene (OMIM 607001) and is
characterized by distinct facial dysmorphism of arched eyebrows,
midface hypoplasia, upturned nares, full everted lower lip, cupid
bowed upper lip and prognathia, congenital heart defects (pri-
marily ventricular septal defect and atrial septal defect) in half of
the affected patients, intellectual disability, developmental delay
and childhood hypotonia, and minor features of genitourinary de-
fects, seizures, and behavior problems [1e7].
We previously reported prenatal diagnosis of 9q34.3 micro-
deletionwith Kleefstra syndrome and 3q26.31-q29 duplication in a
fetus with abnormal ﬁrst-trimester maternal serum screening
result at 12 weeks of gestation: an elevated level of 4.04 MoM of
maternal serum free b-hCG, a level of 1.069MoMofmaternal serum
pregnancy-associated plasma protein-A (PAPP-A), a Down syn-
drome risk of 1/8 and a trisomy 18 risk of 1/136 [8]. We additionally
also reported prenatal diagnosis of mosaic ring chromosome 9 or
r(9)(p24q34.3) in a pregnancy with an abnormal second-trimester
maternal serum screening result at 15 weeks of gestation: a level of
0.63 MoM of maternal serum AFP, a level of 1.15 MoM of maternal
serum free b-hCG level, and a Down syndrome risk of 1/57 [9]. The
present case provides additional evidence that pregnancy with
9q34.3 microdeletion and Kleefstra syndrome in the fetus may be
associated with an abnormal maternal serum screening result but
without abnormal fetal sonographic ﬁndings. The aCGH analysis
has the advantage of detecting microdeletion syndromes in the
fetuses with a normal karyotype by conventional cytogenetic
analysis [10,11]. In this regard, the Kleefstra syndrome may be
detected by prenatal application of aCGH in addition to conven-
tional cytogenetic analysis in the pregnancy with an abnormalby Elsevier Taiwan LLC. All rights reserved.
C.-P. Chen et al. / Taiwanese Journal of Obstetrics & Gynecology 54 (2015) 450e451 451maternal serum screening result. We suggest an application of
aCGH on uncultured amniocytes at prenatal diagnosis of micro-
deletion syndrome in the following pregnancies if necessary.
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